u/elin_varga
Contributes reviews on supplier material. Based in Tilburg.
member · joined 11 Feb 2025
Comments — page 3 of 5
comment on [Results] 56 weeks on 0.25mg, full numbers, ask me anything boring in c/insurancefights · 138 points · 7 months ago
external review is the appeal after insurance says no
comment on [Results] 56 weeks on 0.25mg, full numbers, ask me anything boring in c/insurancefights · 59 points · 7 months ago
Sweden plan: step therapy required 24 medications first. Did them all, got approval. The order matters.
comment on [Vendor] QST order #16 — Denmark, 7 days, no drama, receipts inside in c/tapering · 65 points · 8 months ago
Yeah, regain is not a failure.
comment on [Results] 47 weeks, 46kg, and identity was the hard part in c/researchpeptides · 5 points · 8 months ago
What was the batch number and which service?
comment on rodent data: what the trials say vs what this community says in c/bpc157 · 11 points · 8 months ago
Second this question. I have wondered about tendon for 9 months and never seen a straight answer.
comment on SURMOUNT vs SURPASS — genuinely asking which matters more in c/tirzepatide · 16 points · 9 months ago
the fatigue from tirz is different, not necessarily worse
comment on SURMOUNT vs SURPASS — genuinely asking which matters more in c/tirzepatide · 338 points · 9 months ago
the dual agonism hits different and that is why people describe it differently
comment on SURMOUNT vs SURPASS — genuinely asking which matters more in c/tirzepatide · 72 points · 9 months ago
the 15mg is the top of the pen, not the required dose
comment on is it normal to get injection-site soreness at week 54 in c/glp1canada · 7 points · 9 months ago
special auth turnaround is province-specific
comment on nobody warned me about sulphur burps and I would have liked the warning in c/tirzepatide · 357 points · 10 months ago
That is net peptide content, not purity. Different number, different meaning.
comment on small win: regulatory stopped being a problem at week 71 in c/bpc157 · 49 points · 10 months ago
Yeah, rodent data does not scale to humans.
comment on [Results] 41 weeks on 2.5mg, full numbers, ask me anything boring in c/glp1canada · 2 points · 10 months ago
provincial formularies differ sharply
comment on Canada vs formulary — genuinely asking which matters more in c/glp1canada · 14 points · 11 months ago
name your province, coverage is provincial
comment on copay is the most under-discussed thing in c/labresults in c/insurancefights · 22 points · 1 year ago
This is correct. Appeal letters work.
comment on [Question] Mounjaro — what am I missing here in c/tirzepatide · 78 points · 1 year ago
the dual agonism hits different and that is why people describe it differently
comment on [Discussion] private plan is doing more work than we give it credit for in c/glp1canada · 10 points · 1 year ago
This is correct. Name your province.
comment on help me understand denial, I have read the wiki twice in c/insurancefights · 994 points · 1 year ago
copay is separate from coverage
comment on [Results] 61 weeks on 12.5mg, full numbers, ask me anything boring in c/bloodwork · 29 points · 1 year ago
baseline is the most important eGFR measurement, you cannot collect it later
comment on step therapy — my 7-week log, condensed into one table in c/insurancefights · 431 points · 1 year ago
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
comment on formulary — 13 things I got wrong before I got it right in c/glp1canada · 24 points · 1 year ago
Strongly agree. Provincial variation is real.